Valley Medical Group News

The Okonite Company Makes Second Remarkable Commitment of $5 million in support of Valley Health System’s Clinical Research Program

 

The Okonite Company Makes Second Remarkable Commitment of $5 million in support of Valley Health System’s Clinical Research ProgramThe Okonite Company has made a second extraordinary commitment of $5 million to The Valley Hospital Foundation in support of the Valley Health System’s Translational and Clinical Research programs. Research within Valley Health System is dedicated to advancing medicine and discovering novel medical and surgical approaches to diagnosing and treating diseases in cardiology, oncology, and the neurosciences.

In June 2015, Valley celebrated the opening of the Okonite Research Center, which houses its Center for Cancer Research and Genomic Medicine and the biorepository, one of the first established in New Jersey. The creation of Valley’s research laboratories and expansion of biorepository were created through the tremendous generosity of Okonite.

This new $5 million commitment is being directed to sponsor translational and clinical research initiatives in the Center’s laboratories as well as through the entire Valley Health System. Research conducted at the Center helps provide state-of-the-art clinical care to Valley’s patients as well as be a critical focal point for Valley’s new affiliations with Mount Sinai Health System and Cleveland Clinic.

“We are indebted to Okonite for supporting our ongoing research efforts,” says Anastasios Kozaitis, Valley Hospital Foundation president. “Between our scientists, world-renowned collaborating scientists, and Valley’s state-of-the-art Okonite facility, we are positioned to advance our existing clinical research program while recruiting additional distinguished physicians, and strengthening collaborations with national and international research institutes.”

Audrey Meyers, president and chief executive officer of The Valley Hospital and Valley Health System, states, “Valley’s continued dedication to research helps to advance patient care, offer our patients breakthrough treatments and services, and ensure our continued success as a healthcare system of choice for our community.”

“We are always proud to support the Valley Health System,” said Mr. Victor Viggiano, Chairman and Chief Executive Officer of the Okonite Company. “Valley is committed to excellence and continues to deliver high-quality healthcare to the residents of New Jersey.”

Established in 1980 as a 501(c)(3) charitable organization, the Valley Hospital Foundation raises funds that support the diverse programs and services of the Valley Health System. The Foundation accepts contributions in the form of: direct cash gifts and pledges, matching corporate gifts, planned gifts and naming opportunities. For more information on ways to donate, please contact Sandy Carapezza at 201-291-6300 or acarape@valleyhospitalfoundation.org.

About The Valley Hospital

The Valley Hospital, a 451-bed, acute care, not-for-profit hospital located in Ridgewood, NJ, is part of Valley Health System, which also includes Valley Home Care and Valley Medical Group. Valley is the recipient of numerous awards and recognitions. These include 10 consecutive recognitions for service excellence by J.D. Power and Gold Seals of Approval from the Joint Commission in 12 clinical areas, including six for cancer care, more than any other hospital in the nation. Valley has also been recognized by Healthgrades as one of America’s 100 Best Hospitals for Orthopedic Surgery. Valley has also been honored three times with “Magnet” designation – the nursing profession’s highest honor. Valley is a cardiovascular affiliate of The Cleveland Clinic Heart and Vascular Institute, and has established an academic affiliation with Mount Sinai Health System. Key services include cardiology, oncology, women’s and children’s services, emergency care, orthopedics, and neurosciences.

For more information please visit www.ValleyHealth.com.

About The Okonite Company:

The Okonite Company was founded in 1878 making it one of the original insulators of electrical wire and cable in the United States. Today, Okonite is headquartered in Ramsey NJ, approximately 30 miles northwest of New York City. At its six (6) manufacturing facilities, they make cables that range from 300V to 345kV insulated products that include Instrumentation, Power and Control, Medium Voltage, and High Voltage cables. These cables are manufactured with a variety of insulating and jacketing materials including Okoguard® EPR, laminated polypropylene paper (LPP), and other thermosetting and thermoplastic compounds.

Okonite serves a multitude of industry markets including Electric Utility (Distribution, Transmission, and Generation including fossil and nuclear), Oil & Gas (refineries and production platforms), Chemical, Military bases, Railroad, Transit and Pulp & Paper. In addition, they provide cables to various other industrial customers in areas of: Hospitals, Colleges & Universities, Water Treatment Plants and Data Centers.

Photo: Shown at Valley’s Okonite Research Center (from left to right) are Anastasios Kozaitis, President, The Valley Hospital Foundation; Audrey Meyers, President and CEO, Valley Health System and The Valley Hospital; Victor Viggiano, Chairman and Chief Executive Officer of the Okonite Company; and Mildred Bightly.

Health Headlines